3日龄仔猪经鼻内与肌内途径接种PRRSV MLV疫苗的保护效力比较评估
本研究在3日龄仔猪中比较商品化PRRSV-2 MLV疫苗经鼻内与肌内接种对泰国高致病性PRRSV攻击的保护效力和免疫应答。攻毒后肌内组和鼻内组均较未接种攻毒对照组发热减轻、生长性能改善;鼻内组扁桃体病毒载量显著降低并诱导更强的PRRSV特异性T淋巴细胞应答。
要点
- 3日龄仔猪接种PRRSV-2 MLV后攻毒,肌内组与鼻内组均较未接种攻毒对照组发热减轻、生长改善。
- 肌内组气管支气管淋巴结病毒载量较低,鼻内组扁桃体病毒载量显著降低。
- 鼻内组攻毒后PRRSV特异性产IFN-γ的CD4+和CD8+ T淋巴细胞数量增加。
核心结论
- 3日龄仔猪早期接种PRRSV-2 MLV可减轻HP-PRRSV感染的临床症状并改善生长性能,与接种途径无关。
- 鼻内接种诱导更高的PRRSV特异性T淋巴细胞应答,作者认为其有潜力作为仔猪早期接种的替代策略。
研究设计与样本
- 研究将PRRSV血清阳性母猪所产仔猪随机分为四组:未接种未攻毒对照组(A-NEG)、未接种HP-PRRSV攻毒对照组(B-POS)、肌内接种PRRSV-2 MLV组(C-IM)、鼻内接种PRRSV-2 MLV组(D-IN)。
- 仔猪在3日龄接种,5周龄时B-POS、C-IM和D-IN组用HP-PRRSV攻毒。
主要发现
- 攻毒后C-IM组和D-IN组较B-POS组发热显著减少、生长性能改善。
- C-IM组气管支气管淋巴结病毒载量较低,D-IN组扁桃体病毒载量显著降低。
- 所有组针对HP-PRRSV的中和抗体均较低。
- D-IN组攻毒后PRRSV特异性产IFN-γ的CD4+和CD8+ T淋巴细胞数量增加,系统性T淋巴细胞应答增强。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Early porcine reproductive and respiratory syndrome virus (PRRSV) infections in suckling pigs are commonly observed, emphasizing the need for early vaccination strategies. However, the effectiveness of early vaccination in suckling pigs remains debated due to potential interference from maternally derived antibodies (MDA) and the immature immune system of piglets. This study evaluated and compared protective efficacy and immune responses of intranasal (IN) and intramuscular (IM) administration of a commercial PRRSV-2 modified live virus (MLV) vaccine in 3-day-old piglets against a Thai highly pathogenic (HP)-PRRSV strain. Piglets from PRRSV-seropositive sows were randomly allocated to four groups: unvaccinated, unchallenged control (A-NEG); unvaccinated, HP-PRRSV-challenged control (B-POS); intramuscular vaccination with PRRSV-2 MLV (C-IM); intranasal vaccination with PRRSV-2 MLV (D-IN). At five weeks of age, piglets in the B-POS, C-IM, and D-IN groups were challenged with HP-PRRSV. Following challenge with HP-PRRSV, both C-IM and D-IN groups demonstrated significant reductions in fever and improved growth performance compared to the B-POS group. Notably, the C-IM group exhibited lower viral loads in the tracheobronchial lymph nodes (TBLN), while the D-IN group showed significantly reduced viral loads in the tonsils. As expected, neutralizing antibody against HP-PRRSV was low across all groups. Interestingly, the D-IN group exhibited enhanced systemic T lymphocyte responses, characterized by increased numbers of PRRSV-specific IFN-γ+-producing CD4+ and CD8+ T lymphocytes following viral challenge. Early vaccination of piglets with PRRSV-2 MLV effectively reduced clinical signs and improved growth performance during HP-PRRSV infection, regardless of the administration route. Notably, intranasal vaccination induced higher PRRSV-specific T lymphocytes responses, highlighting its potential as an alternative strategy for early vaccination in piglets. These findings underscore the importance of optimizing vaccination protocols to improve PRRSV control measures in swine farms, particularly against early PRRSV infections.
引用
- Prapattanakullawong A, Sirisereewan C, Boonprakob R, et al. Comparative evaluation of PRRSV MLV vaccine efficacy administered via intranasal and intramuscular routes in early age of piglets. Vaccine. 2025. PMID: 41046831. doi:10.1016/j.vaccine.2025.127822
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。